2006至2014年中国浙江省1至29岁人群乙型肝炎病毒感染报告率与血清流行率显著下降
研究基于国家法定传染病报告系统及2006年与2014年两次血清流行病学调查,评估浙江省1至29岁人群HBV感染报告率与血清流行率变化;结果显示报告发病率下降约4.88倍,HBsAg流行率由2.16%降至1.05%,抗-HBc由7.13%降至5.49%,1至14岁人群抗-HBs保持高水平。
要点
- 2006至2014年浙江省1至29岁人群HBV报告发病率下降约4.88倍。
- HBsAg流行率由2006年2.16%降至2014年1.05%,抗-HBc由7.13%降至5.49%。
- 15至29岁年龄组抗-HBc血清流行率在两次调查中均显著高于其他年龄组。
核心结论
- 通过维持乙肝疫苗首剂及时接种率和三剂次全程接种率的高水平覆盖,浙江省乙肝报告率和HBsAg阳性率显著下降,但实现消除目标仍需额外努力。
研究设计与样本
- 基于国家法定传染病报告系统(NNDRS)获取浙江省2006至2014年HBV感染报告率数据,并比较2006年与2014年两次血清流行病学调查的HBV血清学标志物流行率及免疫覆盖率。
主要发现
- NNDRS报告显示1至29岁人群HBV报告发病率从2006年至2014年下降约4.88倍。
- HBsAg流行率从2006年2.16%降至2014年1.05%,抗-HBc流行率从7.13%降至5.49%。
- 15至29岁年龄组抗-HBc血清流行率在2006年和2014年两次调查中均显著高于其他所有年龄组。
- 1至14岁人群抗-HBs血清流行率在2006年至2014年间维持在较高水平。
关键数值与推荐
- 浙江省自1992年以来乙肝疫苗首剂接种率和三剂次全程接种率均保持在90%以上。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The Chinese government integrated hepatitis B vaccination into the national immunization program in 1992, when the hepatitis B birth dose was introduced in China. Zhejiang province is a relatively developed area in eastern China and was an area with high endemicity for hepatitis B virus (HBV) infection via mother-to-child transmission. The hepatitis B vaccine vaccination rates for the birth dose and 3- dose schedule in Zhejiang Province since 1992 have both remained above 90% [1]. The results of two hepatitis B seroepidemiological surveys conducted in 2006 and 2014, respectively, to evaluate the rates of notification and seroprevalence of HBV infection among the population of Zhejiang Province, China, aged between 1 and 29years. METHODS: Data on the notification rates of HBV infection in Zhejiang province from 2006 to 2014 were obtained from the National Notifiable Disease Reporting System (NNDRS). The prevalence rate of HBV serological markers and the rate of immunization coverage were compared between surveys. RESULTS: The reported notification rates in people aged between 1 and 29years according to the NNDRS decreased approximately 4.88 times from 2006 to 2014. The prevalence of HBsAg decreased from 2.16% in 2006 to 1.05% in 2014, while the prevalence of anti-HBc decreased from 7.13% to 5.49%. The anti-HBc seroprevalence in the 15-29-year-old age group was significantly higher than that in all the other age groups both in the 2006 and 2014 serosurveys. The rate of anti-HBs seroprevalence in those aged between 1 and 14years was maintained at a high level between 2006 and 2014. CONCLUSIONS: The rate of hepatitis B reported and the rate of HBsAg positivity decreased significantly in Zhejiang province by maintaining the high-level coverage rate of the hepatitis B timely birth dose and three-dose schedule. While additional efforts are needed to achieve the goal of elimination.
引用
- Zhou Y, He H, Deng X, et al. Significant reduction in notification and seroprevalence rates of hepatitis B virus infection among the population of Zhejiang Province, China, aged between 1 and 29years from 2006 to 2014. Vaccine. 2017. PMID: 28687404. doi:10.1016/j.vaccine.2017.06.078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。